HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: fj.08-112326v1 22/12/4126    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, Q. Articles by Quigg, R. J. Search for Related Content PubMed PubMed Citation Articles by Wang, Q. Articles by Quigg, R. J.

MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy

The University of Chicago, Section of Nephrology, Department of Medicine, Chicago, Illinois, USA

¹Correspondence: Section of Nephrology, The University of Chicago, 5841 South Maryland Ave., MC5100, AMB-S523, Chicago, IL 60637, USA. E-mail: rquigg{at}uchicago.edu

Intrinsic glomerular cells in a diabetic milieu have transcriptional activation of genes that influence the development of diabetic nephropathy. The cellular repertoire of microRNAs can regulate translation of these expressed genes into proteins. Fibronectin is a key matrix protein accumulated in excess in diabetic nephropathy. Here, we exposed cultured human and mouse mesangial cells to high glucose and transforming growth factor-β to simulate the diabetic milieu. In these conditions in vitro, as well as in mouse diabetic nephropathy models in vivo, microRNA-377 was consistently up-regulated relative to controls. Through a combination of computational and biological approaches, we identified relevant miR-377 target genes. Although fibronectin was induced by miR-377, it was not a direct target of miR-377. However, miR-377 led to reduced expressions of p21-activated kinase and superoxide dismutase, which enhanced fibronectin protein production. Thus, overexpression of miR-377 in diabetic nephropathy indirectly leads to increased fibronectin protein production; as such, miR-377 can have a critical role in the pathophysiology of this prevalent human disease.—Wang, Q., Wang, Y., Minto, A. W., Wang, J., Shi, Q., Li, X., Quigg, R. J. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.

Key Words: diabetes • microRNA • glomerulus • extracellular matrix

This article has been cited by other articles:

				V. Schaeffer, K. M. Hansen, D. R. Morris, and C. K. Abrass Reductions in laminin {beta}2 mRNA translation are responsible for impaired IGFBP-5-mediated mesangial cell migration in the presence of high glucose Am J Physiol Renal Physiol, February 1, 2010; 298(2): F314 - F322. [Abstract] [Full Text] [PDF]

				M. Liang, Y. Liu, D. Mladinov, A. W. Cowley Jr., H. Trivedi, Y. Fang, X. Xu, X. Ding, and Z. Tian MicroRNA: a new frontier in kidney and blood pressure research Am J Physiol Renal Physiol, September 1, 2009; 297(3): F553 - F558. [Abstract] [Full Text] [PDF]

				C. D. Cohen Will non-coding RNAs help to decipher renal allograft failure? Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2325 - 2327. [Full Text] [PDF]

				M. Kato, L. Arce, and R. Natarajan MicroRNAs and Their Role in Progressive Kidney Diseases Clin. J. Am. Soc. Nephrol., July 1, 2009; 4(7): 1255 - 1266. [Abstract] [Full Text] [PDF]